0001225208-22-003667.txt : 20220301
0001225208-22-003667.hdr.sgml : 20220301
20220301160311
ACCESSION NUMBER: 0001225208-22-003667
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220226
FILED AS OF DATE: 20220301
DATE AS OF CHANGE: 20220301
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LANKLER DOUGLAS M
CENTRAL INDEX KEY: 0001488270
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03619
FILM NUMBER: 22697861
MAIL ADDRESS:
STREET 1: PFIZER INC. ATTN: CORPORATE SECRETARY
STREET 2: 235 EAST 42ND STREET
CITY: NEW YORK
STATE: NY
ZIP: 10017
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PFIZER INC
CENTRAL INDEX KEY: 0000078003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 135315170
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 2125732323
MAIL ADDRESS:
STREET 1: 235 E 42ND ST
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: PFIZER CHARLES & CO INC
DATE OF NAME CHANGE: 19710908
4
1
doc4.xml
X0306
4
2022-02-26
0000078003
PFIZER INC
PFE
0001488270
LANKLER DOUGLAS M
PFIZER INC.-CORP. SECRETARY
235 EAST 42ND ST.
NEW YORK
NY
10017
1
Executive Vice President
Common Stock
2022-02-26
4
M
0
77709.0000
25.6000
A
174507.0000
D
Common Stock
2022-02-26
4
F
0
21149.0000
47.7200
D
153358.0000
D
Common Stock
2022-02-26
4
F
0
36282.0000
50.6400
D
117076.0000
D
Common Stock
1681.0000
I
By Rule 16b-3 Plan
Stock Appreciation Rights
25.6000
2022-02-26
4
M
0
77709.0000
0.0000
D
2022-02-26
2022-02-26
Common Stock
77709.0000
0.0000
D
Stock Appreciation Rights
46.9400
2022-02-28
4
A
0
10566.0000
0.0000
A
2027-02-28
2027-02-28
Common Stock
10566.0000
10566.0000
D
Stock Appreciation Rights
46.9400
2022-02-28
4
A
0
9294.0000
0.0000
A
2029-02-28
2029-02-28
Common Stock
9294.0000
9294.0000
D
The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
Price is the closing price of Pfizer common stock on February 25, 2022.
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.
The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.
Susan E. Grant, by power of atty., for Douglas M. Lankler
2022-03-01